Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YD0743 in Sepsis-Associated ARDS
NCT07413094Phase 2Recruiting
- Sponsor
- Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
- Start
- Feb 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of YD0743 in acute respiratory distress syndrome (ARDS), sponsored by Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.. Started Feb 2026; status: recruiting.
02
Drugs
YD0743
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT07413094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07413094.